HRP20120460T1 - Novi 5-supstituirani hidantoini - Google Patents

Novi 5-supstituirani hidantoini Download PDF

Info

Publication number
HRP20120460T1
HRP20120460T1 HRP20120460AT HRP20120460T HRP20120460T1 HR P20120460 T1 HRP20120460 T1 HR P20120460T1 HR P20120460A T HRP20120460A T HR P20120460AT HR P20120460 T HRP20120460 T HR P20120460T HR P20120460 T1 HRP20120460 T1 HR P20120460T1
Authority
HR
Croatia
Prior art keywords
compound
general formula
image
aryl
branched
Prior art date
Application number
HRP20120460AT
Other languages
English (en)
Croatian (hr)
Inventor
Sarakinos Georgios
Hubertus Joseph Boesten Wilhelmus
Heemskerk Dennis
De Lange Ben
Original Assignee
Dsm Sinochem Pharmaceuticals Netherlands B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Sinochem Pharmaceuticals Netherlands B.V. filed Critical Dsm Sinochem Pharmaceuticals Netherlands B.V.
Publication of HRP20120460T1 publication Critical patent/HRP20120460T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/80Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HRP20120460AT 2007-06-06 2012-05-29 Novi 5-supstituirani hidantoini HRP20120460T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07109684 2007-06-06
PCT/EP2008/056841 WO2008148755A2 (fr) 2007-06-06 2008-06-03 Nouvelles hydantoïnes 5-substituées

Publications (1)

Publication Number Publication Date
HRP20120460T1 true HRP20120460T1 (hr) 2012-06-30

Family

ID=38802392

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20120460AT HRP20120460T1 (hr) 2007-06-06 2012-05-29 Novi 5-supstituirani hidantoini

Country Status (8)

Country Link
US (1) US8420683B2 (fr)
EP (1) EP2150538B1 (fr)
CN (1) CN101679295A (fr)
AT (1) ATE551328T1 (fr)
HK (1) HK1141029A1 (fr)
HR (1) HRP20120460T1 (fr)
SI (1) SI2150538T1 (fr)
WO (1) WO2008148755A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2397764T3 (es) 2008-04-01 2013-03-11 Abbott Gmbh & Co. Kg Tetrahidroisoquinolinas, composiciones farmacéuticas que las contienen, y su uso en terapia
AR075442A1 (es) 2009-02-16 2011-03-30 Abbott Gmbh & Co Kg Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
US8883839B2 (en) 2010-08-13 2014-11-11 Abbott Laboratories Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9045459B2 (en) 2010-08-13 2015-06-02 AbbVie Deutschland GmbH & Co. KG Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8846743B2 (en) 2010-08-13 2014-09-30 Abbott Laboratories Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US8877794B2 (en) 2010-08-13 2014-11-04 Abbott Laboratories Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9051280B2 (en) 2010-08-13 2015-06-09 AbbVie Deutschland GmbH & Co. KG Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9309200B2 (en) 2011-05-12 2016-04-12 AbbVie Deutschland GmbH & Co. KG Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
JP2014521682A (ja) 2011-08-05 2014-08-28 アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー アミノクロマン、アミノチオクロマンおよびアミノ−1,2,3,4−テトラヒドロキノリン誘導体、これらを含有する医薬組成物、ならびに治療におけるこれらの使用
US8846741B2 (en) 2011-11-18 2014-09-30 Abbvie Inc. N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9365512B2 (en) 2012-02-13 2016-06-14 AbbVie Deutschland GmbH & Co. KG Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
US9650334B2 (en) 2013-03-15 2017-05-16 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9656955B2 (en) 2013-03-15 2017-05-23 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
KR20160062165A (ko) 2013-10-17 2016-06-01 아비에 도이치란트 게엠베하 운트 콤파니 카게 아미노테트랄린 및 아미노인단 유도체, 이들을 포함하는 약제학적 조성물, 및 치료에서 이들의 용도
SG11201602982YA (en) 2013-10-17 2016-05-30 Abbvie Deutschland Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
SG11201704764PA (en) 2014-12-11 2017-07-28 Harvard College Inhibitors of cellular necrosis and related methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4316928C2 (de) 1993-05-19 1995-03-16 Degussa Neue Mikroorganismen, deren Verwendung und Verfahren zur Herstellung von L-alpha-Aminosäuren
AR036187A1 (es) * 2001-07-24 2004-08-18 Adir Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
PL367931A1 (en) * 2004-05-12 2005-11-14 Instytut Farmaceutyczny Method for manufacture of 2-[n-[(s)-1- etoxycarbonyl-3-phenyl propyl]-(s)-alanyl] -(1s,3s,5s)-2-azabicyclo [3.3.0] octane-3-carboxylic acid
US20100143981A1 (en) * 2006-12-04 2010-06-10 Rusnak-Mueller Monika Whole-cell catalytic system comprising a hydantoinase, a racemase and a carbamoylase

Also Published As

Publication number Publication date
EP2150538B1 (fr) 2012-03-28
EP2150538A2 (fr) 2010-02-10
CN101679295A (zh) 2010-03-24
ATE551328T1 (de) 2012-04-15
SI2150538T1 (sl) 2012-07-31
HK1141029A1 (en) 2010-10-29
US20100174092A1 (en) 2010-07-08
WO2008148755A3 (fr) 2009-02-12
WO2008148755A2 (fr) 2008-12-11
US8420683B2 (en) 2013-04-16

Similar Documents

Publication Publication Date Title
HRP20120460T1 (hr) Novi 5-supstituirani hidantoini
WO2020227549A8 (fr) MODULATEURS DE THR-β ET LEURS PROCÉDÉS D'UTILISATION
ATE530066T1 (de) Verbindungen zur behandlung von stoffwechselstörungen
TW200724136A (en) Pharmaceutical compositions comprising PPAR modulator
RS54708B1 (en) ARYLETINYL DERIVATIVES
RS53569B1 (en) NEW COMPOUNDS AND COMPOSITIONS, AND PROCEDURES FOR USE
RS52247B (en) SUBSTITUTED PHENOXES N-ALKYLED THIAZOLDINDION AS MODULATORS OF ESTROGEN RELATED ALFA-RECEPTORS
CA2549431A1 (fr) Sel d'ammonium quaternaire optiquement actif ayant une asymetrie axiale et processus de production d'un acide .alpha.-amino et de son derive avec celui-ci
CY1111310T1 (el) Ενωσεις για την αγωγη μεταβολικων διαταραχων
HRP20110964T1 (hr) PIPERIDINSKI AGONISTI GPCR-a
AR045651A1 (es) Derivados de tiazol como moduladores del receptor de cannabinoide
IN2014CN02478A (fr)
RS53903B1 (en) ETHINYL DERIVATIVES AS POSITIVE MGLUR5 MODULATORS
EP2161997A1 (fr) Inhibiteurs tricycliques de l'hydrolase amide des acides gras faah
MX338631B (es) 5-(fenil/piridinil-etinil)-2-piridina/ 2-pirimidina-carboxamidas como moduladores del receptor de glutamato metabotropico del subtipo 5 (mglur5).
ATE540675T1 (de) Verbindungen zur behandlung von stoffwechselstörungen
MX345873B (es) Derivados de arilalquilaminocarboxamida fluorados.
PL2155736T3 (pl) Nowy związek, karbamoiloksyaryloalkanoiloarylopiperazyna, kompozycje farmaceutyczne zawierające ten związek oraz sposoby leczenia bólu, stanu lękowego i depresji przez podawanie tego związku
MY165141A (en) Pyrazolidin-3-one derivatives
HRP20150068T1 (hr) Sinteza aliskirena
WO2006002802A8 (fr) Derives phenyle comprenant un groupe acetylene
BRPI0519948A2 (pt) composto, processo para a preparação de um composto, composição farmacêutica e método de tratamento de cáncer em um mamìfero
FR3024734A1 (fr) Polymere dote de proprietes d'adherence
MX2014003636A (es) Derivados de etinilo como moduladores del receptor glutamato metabotropico.
DE602005026805D1 (de) Immunoinhibitorische heterocyclische verbindungen